Large cancer panel test

Summary

The tender concerns a large cancer panel test for HUS Diagnostic Center. It covers gene panels and reagents, plus data analysis software for reporting clinically significant variants, copy number alterations and gene fusions. The procurement is divided into two lots: Lot A for in-house NGS testing of solid tumors and hematological malignancies, and Lot B for in-house NGS testing of cell-free DNA. The tenderer may bid for one or both lots. The contract is planned to start in autumn-winter 2026, and the estimated annual volume is 2,500–3,000 tests.